1 | author | 2,304 |
2 | epidemic | 1,446 |
3 | object | 1,079 |
4 | reviewer | 719 |
5 | outbreak | 565 |
6 | outlier | 111 |
7 | actor | 87 |
8 | exemplar | 52 |
9 | enigma | 40 |
10 | opponent | 38 |
11 | trialist | 25 |
12 | tournament | 24 |
13 | epizootic | 16 |
14 | electrophile | 13 |
15 | post-pandemic | 12 |
16 | eriksen | 10 |
17 | l-cat | 10 |
18 | rains | 9 |
19 | regressor | 9 |
20 | alphaherpesvirus | 8 |
21 | exostosis | 8 |
22 | nci-ccc | 7 |
23 | 3'hp | 6 |
24 | attractor | 6 |
25 | hdm-impermeable | 6 |
26 | b-strain | 5 |
27 | interlocutor | 5 |
28 | non-kin | 5 |
29 | transfixator | 5 |
30 | anklet | 4 |
31 | eyetracker | 4 |
32 | endodontist | 3 |
33 | exhilarating | 3 |
34 | holothurin | 3 |
35 | hrv-ca | 3 |
36 | immunopotentiator | 3 |
37 | lr-model | 3 |
38 | microwatt | 3 |
39 | oh-group | 3 |
40 | rapidloc | 3 |
41 | sils2 | 3 |
42 | 4,6,8-triarylquinoline-3-carbaldehydes | 2 |
43 | alkylindoles | 2 |
44 | alpha-epimers | 2 |
45 | anthropozoonosis | 2 |
46 | audio-drama | 2 |
47 | d-separation | 2 |
48 | ectoparasitosis | 2 |
49 | epilogue | 2 |
50 | escrs | 2 |
51 | gamma-factor | 2 |
52 | gombrich | 2 |
53 | holotoxins | 2 |
54 | ibpab-disrupted | 2 |
55 | in-docking-mode | 2 |
56 | lutetacyclopentadiene | 2 |
57 | macquarie | 2 |
58 | monoacylglyceryltrimethylhomoserine | 2 |
59 | nidep-study | 2 |
60 | odd-ball | 2 |
61 | odstock | 2 |
62 | pama | 2 |
63 | reward/punishment | 2 |
64 | sahtu | 2 |
65 | salesperson | 2 |
66 | slhc | 2 |
67 | ua1 | 2 |
68 | urotoxicity | 2 |
69 | 0.49-0.53 | 1 |
70 | 1.6-s | 1 |
71 | 1.91±1.3 | 1 |
72 | 158,177 | 1 |
73 | adolescents.mdft | 1 |
74 | ampb-resistant | 1 |
75 | anabaenopeptin-producing | 1 |
76 | auther | 1 |
77 | bacterial/mouse | 1 |
78 | before-injection | 1 |
79 | best-ranked | 1 |
80 | carpie-study | 1 |
81 | cbo-di-gsh | 1 |
82 | conditional∕transition | 1 |
83 | cut-planes | 1 |
84 | detrusor-sphincter-dyscoordination | 1 |
85 | dienediol | 1 |
86 | eblv-1b | 1 |
87 | epocs | 1 |
88 | epsilon-value | 1 |
89 | eye.it | 1 |
90 | freemartin | 1 |
91 | ggti | 1 |
92 | gmm-estimated | 1 |
93 | harm.benefit | 1 |
94 | harmonic-vibrational | 1 |
95 | hematologist-oncologist | 1 |
96 | imidacloprid-resistant | 1 |
97 | impact/shock | 1 |
98 | infection.this | 1 |
99 | institution/investigator | 1 |
100 | intertervertebral | 1 |
101 | intervariability | 1 |
102 | lbbb-related | 1 |
103 | lead-resistant | 1 |
104 | lfmcsm | 1 |
105 | neuro-radiologist | 1 |
106 | nnipps-pps | 1 |
107 | oratio | 1 |
108 | over-extraction | 1 |
109 | oxa-48-carrying | 1 |
110 | pdwrc | 1 |
111 | plco-study | 1 |
112 | prevention-today | 1 |
113 | proc-ess | 1 |
114 | rain-forest | 1 |
115 | rct-report | 1 |
116 | research-ii | 1 |
117 | sgrna | 1 |
118 | sprna | 1 |
119 | studyparticipants | 1 |
120 | tangiwai | 1 |
121 | test-inadequate | 1 |
122 | test-retested | 1 |
123 | tetrahydro-beta-carbolines | 1 |
124 | trans-complemented | 1 |
1 | 0.49-0.53 | 1 |
2 | 1.6-s | 1 |
3 | 1.91±1.3 | 1 |
4 | 158,177 | 1 |
5 | 3'hp | 6 |
6 | 4,6,8-triarylquinoline-3-carbaldehydes | 2 |
7 | actor | 87 |
8 | adolescents.mdft | 1 |
9 | alkylindoles | 2 |
10 | alpha-epimers | 2 |
11 | alphaherpesvirus | 8 |
12 | ampb-resistant | 1 |
13 | anabaenopeptin-producing | 1 |
14 | anklet | 4 |
15 | anthropozoonosis | 2 |
16 | attractor | 6 |
17 | audio-drama | 2 |
18 | auther | 1 |
19 | author | 2,304 |
20 | b-strain | 5 |
21 | bacterial/mouse | 1 |
22 | before-injection | 1 |
23 | best-ranked | 1 |
24 | carpie-study | 1 |
25 | cbo-di-gsh | 1 |
26 | conditional∕transition | 1 |
27 | cut-planes | 1 |
28 | d-separation | 2 |
29 | detrusor-sphincter-dyscoordination | 1 |
30 | dienediol | 1 |
31 | eblv-1b | 1 |
32 | ectoparasitosis | 2 |
33 | electrophile | 13 |
34 | endodontist | 3 |
35 | enigma | 40 |
36 | epidemic | 1,446 |
37 | epilogue | 2 |
38 | epizootic | 16 |
39 | epocs | 1 |
40 | epsilon-value | 1 |
41 | eriksen | 10 |
42 | escrs | 2 |
43 | exemplar | 52 |
44 | exhilarating | 3 |
45 | exostosis | 8 |
46 | eye.it | 1 |
47 | eyetracker | 4 |
48 | freemartin | 1 |
49 | gamma-factor | 2 |
50 | ggti | 1 |
51 | gmm-estimated | 1 |
52 | gombrich | 2 |
53 | harm.benefit | 1 |
54 | harmonic-vibrational | 1 |
55 | hdm-impermeable | 6 |
56 | hematologist-oncologist | 1 |
57 | holothurin | 3 |
58 | holotoxins | 2 |
59 | hrv-ca | 3 |
60 | ibpab-disrupted | 2 |
61 | imidacloprid-resistant | 1 |
62 | immunopotentiator | 3 |
63 | impact/shock | 1 |
64 | in-docking-mode | 2 |
65 | infection.this | 1 |
66 | institution/investigator | 1 |
67 | interlocutor | 5 |
68 | intertervertebral | 1 |
69 | intervariability | 1 |
70 | l-cat | 10 |
71 | lbbb-related | 1 |
72 | lead-resistant | 1 |
73 | lfmcsm | 1 |
74 | lr-model | 3 |
75 | lutetacyclopentadiene | 2 |
76 | macquarie | 2 |
77 | microwatt | 3 |
78 | monoacylglyceryltrimethylhomoserine | 2 |
79 | nci-ccc | 7 |
80 | neuro-radiologist | 1 |
81 | nidep-study | 2 |
82 | nnipps-pps | 1 |
83 | non-kin | 5 |
84 | object | 1,079 |
85 | odd-ball | 2 |
86 | odstock | 2 |
87 | oh-group | 3 |
88 | opponent | 38 |
89 | oratio | 1 |
90 | outbreak | 565 |
91 | outlier | 111 |
92 | over-extraction | 1 |
93 | oxa-48-carrying | 1 |
94 | pama | 2 |
95 | pdwrc | 1 |
96 | plco-study | 1 |
97 | post-pandemic | 12 |
98 | prevention-today | 1 |
99 | proc-ess | 1 |
100 | rain-forest | 1 |
101 | rains | 9 |
102 | rapidloc | 3 |
103 | rct-report | 1 |
104 | regressor | 9 |
105 | research-ii | 1 |
106 | reviewer | 719 |
107 | reward/punishment | 2 |
108 | sahtu | 2 |
109 | salesperson | 2 |
110 | sgrna | 1 |
111 | sils2 | 3 |
112 | slhc | 2 |
113 | sprna | 1 |
114 | studyparticipants | 1 |
115 | tangiwai | 1 |
116 | test-inadequate | 1 |
117 | test-retested | 1 |
118 | tetrahydro-beta-carbolines | 1 |
119 | tournament | 24 |
120 | trans-complemented | 1 |
121 | transfixator | 5 |
122 | trialist | 25 |
123 | ua1 | 2 |
124 | urotoxicity | 2 |
1 | ua1 | 2 |
2 | sils2 | 3 |
3 | 1.91±1.3 | 1 |
4 | 0.49-0.53 | 1 |
5 | 158,177 | 1 |
6 | hrv-ca | 3 |
7 | pama | 2 |
8 | audio-drama | 2 |
9 | enigma | 40 |
10 | sgrna | 1 |
11 | sprna | 1 |
12 | eblv-1b | 1 |
13 | nci-ccc | 7 |
14 | slhc | 2 |
15 | epidemic | 1,446 |
16 | post-pandemic | 12 |
17 | epizootic | 16 |
18 | rapidloc | 3 |
19 | pdwrc | 1 |
20 | best-ranked | 1 |
21 | lbbb-related | 1 |
22 | gmm-estimated | 1 |
23 | trans-complemented | 1 |
24 | ibpab-disrupted | 2 |
25 | test-retested | 1 |
26 | in-docking-mode | 2 |
27 | macquarie | 2 |
28 | hdm-impermeable | 6 |
29 | electrophile | 13 |
30 | lutetacyclopentadiene | 2 |
31 | monoacylglyceryltrimethylhomoserine | 2 |
32 | bacterial/mouse | 1 |
33 | test-inadequate | 1 |
34 | epilogue | 2 |
35 | epsilon-value | 1 |
36 | anabaenopeptin-producing | 1 |
37 | exhilarating | 3 |
38 | oxa-48-carrying | 1 |
39 | gombrich | 2 |
40 | cbo-di-gsh | 1 |
41 | tangiwai | 1 |
42 | research-ii | 1 |
43 | ggti | 1 |
44 | outbreak | 565 |
45 | impact/shock | 1 |
46 | odstock | 2 |
47 | harmonic-vibrational | 1 |
48 | intertervertebral | 1 |
49 | lr-model | 3 |
50 | odd-ball | 2 |
51 | dienediol | 1 |
52 | lfmcsm | 1 |
53 | eriksen | 10 |
54 | b-strain | 5 |
55 | non-kin | 5 |
56 | holothurin | 3 |
57 | freemartin | 1 |
58 | detrusor-sphincter-dyscoordination | 1 |
59 | d-separation | 2 |
60 | over-extraction | 1 |
61 | before-injection | 1 |
62 | conditional∕transition | 1 |
63 | salesperson | 2 |
64 | oratio | 1 |
65 | 3'hp | 6 |
66 | oh-group | 3 |
67 | exemplar | 52 |
68 | auther | 1 |
69 | outlier | 111 |
70 | eyetracker | 4 |
71 | reviewer | 719 |
72 | author | 2,304 |
73 | regressor | 9 |
74 | institution/investigator | 1 |
75 | immunopotentiator | 3 |
76 | transfixator | 5 |
77 | actor | 87 |
78 | gamma-factor | 2 |
79 | attractor | 6 |
80 | interlocutor | 5 |
81 | 1.6-s | 1 |
82 | epocs | 1 |
83 | 4,6,8-triarylquinoline-3-carbaldehydes | 2 |
84 | alkylindoles | 2 |
85 | cut-planes | 1 |
86 | tetrahydro-beta-carbolines | 1 |
87 | infection.this | 1 |
88 | anthropozoonosis | 2 |
89 | ectoparasitosis | 2 |
90 | exostosis | 8 |
91 | rains | 9 |
92 | holotoxins | 2 |
93 | nnipps-pps | 1 |
94 | escrs | 2 |
95 | alpha-epimers | 2 |
96 | proc-ess | 1 |
97 | studyparticipants | 1 |
98 | alphaherpesvirus | 8 |
99 | l-cat | 10 |
100 | object | 1,079 |
101 | anklet | 4 |
102 | adolescents.mdft | 1 |
103 | eye.it | 1 |
104 | harm.benefit | 1 |
105 | ampb-resistant | 1 |
106 | lead-resistant | 1 |
107 | imidacloprid-resistant | 1 |
108 | tournament | 24 |
109 | reward/punishment | 2 |
110 | opponent | 38 |
111 | rct-report | 1 |
112 | rain-forest | 1 |
113 | hematologist-oncologist | 1 |
114 | neuro-radiologist | 1 |
115 | trialist | 25 |
116 | endodontist | 3 |
117 | microwatt | 3 |
118 | sahtu | 2 |
119 | prevention-today | 1 |
120 | carpie-study | 1 |
121 | plco-study | 1 |
122 | nidep-study | 2 |
123 | urotoxicity | 2 |
124 | intervariability | 1 |